These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9562586)

  • 1. Hypertrophic cardiomyopathy--beyond the sarcomere.
    St John Sutton M; Epstein JA
    N Engl J Med; 1998 Apr; 338(18):1303-4. PubMed ID: 9562586
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
    Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
    N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
    J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic basis of hypertrophic cardiomyopathy.
    Lind JM; Chiu C; Semsarian C
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):927-34. PubMed ID: 17173506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular etiology of idiopathic cardiomyopathy in Asian populations.
    Kimura A; Ito-Satoh M; Hayashi T; Takahashi M; Arimura T
    J Cardiol; 2001; 37 Suppl 1():139-46. PubMed ID: 11433818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcomere gene mutations--a cause of hypertrophic cardiomyopathy].
    Kuusisto J; Jääskeläinen P; Laakso M
    Duodecim; 1999; 115(9):997-8. PubMed ID: 11877825
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy.
    Maron BJ; Yeates L; Semsarian C
    Am J Cardiol; 2011 Feb; 107(4):604-8. PubMed ID: 21185001
    [No Abstract]   [Full Text] [Related]  

  • 9. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C].
    García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L
    Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to Think Differently About Sarcomere-Negative Hypertrophic Cardiomyopathy.
    Watkins H
    Circulation; 2021 Jun; 143(25):2415-2417. PubMed ID: 34152793
    [No Abstract]   [Full Text] [Related]  

  • 11. Variable Penetrance in Hypertrophic Cardiomyopathy: In Search of the Holy Grail.
    Semsarian C; Semsarian CR
    J Am Coll Cardiol; 2020 Aug; 76(5):560-562. PubMed ID: 32731934
    [No Abstract]   [Full Text] [Related]  

  • 12. Fabry Disease and/or Hypertrophic Cardiomyopathy.
    Anan R
    Int Heart J; 2017 May; 58(3):305-306. PubMed ID: 28539575
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertrophic cardiomyopathy].
    Bundgaard H; Havndrup O; Høst U; Kelbaek H
    Ugeskr Laeger; 1998 Sep; 160(38):5478-83. PubMed ID: 9763919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.
    Kaski JP; Syrris P; Burch M; Tomé-Esteban MT; Fenton M; Christiansen M; Andersen PS; Sebire N; Ashworth M; Deanfield JE; McKenna WJ; Elliott PM
    Heart; 2008 Nov; 94(11):1478-84. PubMed ID: 18467357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G263X MYBPC3 mutation is a common and low-penetrant mutation for hypertrophic cardiomyopathy in the region of Asturias (Northern Spain).
    Reguero JR; Gómez J; Martín M; Flórez JP; Morís C; Iglesias S; Alonso B; Alvarez V; Coto E
    Int J Cardiol; 2013 Oct; 168(4):4555-6. PubMed ID: 23870641
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy.
    Christiaans I; Birnie E; Bonsel GJ; Wilde AA; van Langen IM
    Eur J Hum Genet; 2008 Oct; 16(10):1201-7. PubMed ID: 18478037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in hypertrophic cardiomyopathies, part I.
    Roberts R; Sigwart U
    Circulation; 2001 Oct; 104(17):2113-6. PubMed ID: 11673355
    [No Abstract]   [Full Text] [Related]  

  • 19. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutations in sarcomere protein genes as a cause of heart failure].
    Hasegawa H; Komuro I
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():267-72. PubMed ID: 17508564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.